GLENMEDE TRUST CO NA - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$291,188
-2.9%
15,774
+41.7%
0.00%0.0%
Q3 2022$300,000
+512.2%
11,133
+467.7%
0.00%
Q3 2020$49,000
+6.5%
1,961
+3.2%
0.00%
Q2 2020$46,000
-14.8%
1,900
-43.8%
0.00%
Q1 2020$54,0000.0%3,3820.0%0.00%
Q4 2019$54,000
+22.7%
3,382
-2.0%
0.00%
Q3 2019$44,0000.0%3,4500.0%0.00%
Q2 2019$44,000
+4300.0%
3,450
+3036.4%
0.00%
Q1 2019$1,000
-50.0%
1100.0%0.00%
Q4 2018$2,0001100.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders